Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

793.26
-14.3900-1.78%
Pre-market: 831.7138.45+4.85%06:22 EDT
Volume:526.91K
Turnover:419.07M
Market Cap:81.67B
PE:19.62
High:806.14
Open:794.36
Low:792.00
Close:807.65
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.88
T/O Rate:0.53%
Dividend:3.64
Dividend Rate:0.46%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.58
PE(LYR):19.12

Loading ...

Movement Alert|Regeneron Pharmaceuticals Rises 3.06% in Regular Trading, Selected for FDA Accelerated New Production Facility Review Program

Market Focus
·
Jul 07

Regeneron price target lowered to $769 from $778 at Truist

TIPRANKS
·
Jul 07

RBC Capital Adjusts Regeneron Pharmaceuticals Price Target to $696 From $707, Maintains Sector Perform Rating

MT Newswires Live
·
Jul 07

Regeneron Pharmaceuticals Inc : Truist Securities Cuts Target Price to $769 from $778

THOMSON REUTERS
·
Jul 07

Regeneron Pharma is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 06

HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $990

MT Newswires Live
·
Jul 06

Regeneron price target lowered to $750 from $785 at Cantor Fitzgerald

TIPRANKS
·
Jul 06

Regeneron Pharmaceuticals - Expects Q2 2026 Bought Ipr&d Charge of $127 Mln Pre-tax - SEC Filing

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals - Expects Q2 2026 Gaap and Non-gaap Net Income Per Diluted Share to Decrease by $1 - SEC Filing

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals Inc Q2 Shr View $10.81

THOMSON REUTERS
·
Jul 06

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Reuters
·
Jul 06

Eli Lilly, Regeneron Among First Companies Selected for FDA Initiative to Speed Review of New Manufacturing Facilities - CNBC

Reuters
·
Jul 06

Regeneron Pharmaceuticals Inc : HSBC Cuts Target Price to $800 from $990

THOMSON REUTERS
·
Jul 06

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Movement Alert|Regeneron Pharmaceuticals Rises 3.1% in Regular Trading, Selected for FDA Production Pilot Plus Priority Review for Novel Drug

Market Focus
·
Jul 02

Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)

TIPRANKS
·
Jul 01

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01

US FDA - Amneal, Cellares, Eli Lilly, Fujifilm, Kriya, Kyowa Kirin, Regeneron Join FDA Precheck Pilot

THOMSON REUTERS
·
Jun 30

Market Chatter: Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program

MT Newswires Live
·
Jun 30

Lilly, Regeneron Selected for US Program to Review New Manufacturing Plants Faster

Reuters
·
Jun 30